Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time – many blockbusters to fade this year: semaglutide’s India reckoning; multinationals look beyond simple China licensing; Almirall eyes China dermatology assets; EU urged to restore biopharma competitiveness.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-KZ6RVPJK6BAADJKFNBUNOTMB6M/
Podden och tillhörande omslagsbild på den här sidan tillhör
Citeline. Innehållet i podden är skapat av Citeline och inte av,
eller tillsammans med, Poddtoppen.
